You are here:Home
»
Molecular Biology
»
MB-Cancer Markers
»
Carcinoembryonic Antigen, Human, Native, 80+% (CEA, CD66e)
Carcinoembryonic Antigen, Human, Native, 80+% (CEA, CD66e)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Carcinoembryonic antigen (CEA) is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. | | | Catalog # | C1300-15 | | Applications | Suitable for use in ELISA or antigenic applications in immunological protocols. Other applications not tested. | | Recommended Dilutions | Optimal dilutions to be determined by the researcher. | | Storage and Stability | Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | | CAS Number | n/a | | Source | Purified human colon carcinoma liver metastases | | Purity | Purified by immunoaffinity chromatography. ~80% (SDS-PAGE) | | Concentration | 2mg/ml | | Form | Supplied as a liquid in PBS, pH 7.5, 0.05% sodium azide | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|
